CAMBRIDGE, Mass.–(BUSINESS WIRE)–June 14, 2017–

Seven Bridges, the biomedical data analysis company, today announced that Michael Hultner, PhD, Chief Strategy Officer of Seven Bridges, will present on a panel addressing Software-Defined Science: Case Studies In Applied Data/Analytics at the Cowen and Company FutureHealth Conference in San Francisco on June 21, 2017 at 2:30 p.m. PT.

About Seven Bridges
Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. The scalable, cloud-based Seven Bridges Platform empowers rapid, collaborative analysis of millions of genomes in concert with other forms of biomedical data. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics England’s 100,000 Genomes Project. As the NIH’s only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the world’s largest cancer genomics dataset. Named one of the world’s smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Cambridge, Mass.; Belgrade; London; Istanbul; Ankara; and San Francisco.

Media Contact
Seven Bridges
Andrew Gruen, +1 617-294-6582
or
Investor Contact
Stern Investor Relations, Inc.
Stephanie Ascher, 212-362-1200
stephanie@sternir.com